Please login to the form below

Not currently logged in

Ypsomed’s touch screen insulin pump for Novo Nordisk approved by EMA

mylife YpsoPump given green light for use with pump cartridge NovoRapid PumpCart
Novo Nordisk

The European Medicines Agency has approved YpsoPump's touch screen insulin pump, mylife YpsoPump.

Created by diabetes self-care company Ypsomed following a collaboration with Novo Nordisk, the insulin pump is designed to simplify therapy, making it easier for people with diabetes to treat their condition at home.

The mylife YpsoPump is fitted with a touch screen, reducing the need for training, and is fully compatible with Novo Nordisk's prefilled pump cartridge, NovoRapid PumpCart, which negates the need for patients to fill cartridges themselves.

NovoRapid was awarded a European license in 1999 and is currently used with the Accu-Chek Insight pump, manufactured by Roche's diabetes care division.

Dr Mark Evans, a lecturer in medicine at the University of Cambridge and honorary consultant with NovoNordisk, explained that while insulin pump therapy is an effective diabetes therapy, “operating a traditional insulin pump and manually filling the insulin reservoir can be complex and time-consuming”.

He added: “Given these factors, and the burden put upon health systems to train patients to use traditional pumps, efforts to simplify the process are truly welcomed.”

Novo Nordisk is currently the world's biggest seller of diabetes medicines, displacing Sanofi last year. It's GLP-1 agonist Victoza (liraglutide) brought in sales of $2bn in 2014 alone, and is predicted for further growth after trial results published earlier this month showed positive cardiovascular outcomes that went “beyond expectations”.

The firm is also ramping up its disease awareness work, launching an online diabetes management resource - Hypo Hub - with the aim of educating UK patients and the public on the signs and impact of hypos.

Article by
Rebecca Clifford

30th June 2016

From: Regulatory



Featured jobs

Subscribe to our email news alerts


Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....